Inna Starskaia

ORCID: 0000-0003-4349-439X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Diabetes and associated disorders
  • Immune Cell Function and Interaction
  • Pancreatic function and diabetes
  • Cytokine Signaling Pathways and Interactions
  • Immunotherapy and Immune Responses
  • Diabetes Management and Research
  • Eosinophilic Disorders and Syndromes
  • Cancer Immunotherapy and Biomarkers
  • Chemical and Physical Studies
  • Medical and Biological Sciences
  • Acute Myeloid Leukemia Research
  • Galectins and Cancer Biology
  • Monoclonal and Polyclonal Antibodies Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Whipple's Disease and Interleukins

University of Turku
2018-2024

Åbo Akademi University
2018-2024

Turku Centre for Computer Science
2020-2024

Turku Centre for Biotechnology
2018

Tomi Suomi Inna Starskaia Ubaid Ullah Kalim Omid Rasool Maria K. Jaakkola and 95 more Toni Grönroos Tommi Välikangas Caroline Brorsson Gianluca Mazzoni Sylvaine F. A. Bruggraber Lut Overbergh David B. Dunger Mark Peakman Piotr Jaroslaw Chmura Søren Brunak Anke M. Schulte Chantal Mathieu Mikael Knip Riitta Lahesmaa Laura L. Elo Chantal Mathieu Pieter Gillard Kristina Casteels Lutgart Overbergh David B. Dunger Chris Wallace Mark L. Evans Ajay Thankamony Emile Hendriks Sylvaine F. A. Bruggraber Loredana Marcoveccchio Mark Peakman Timothy Tree Noel G. Morgan Sarah J. Richardson John A. Todd Linda S. Wicker Adrian Mander Colin Dayan Mohammad Alhadj Ali Thomas R. Pieber Décio L. Eizirik Myriam Cnop Søren Brunak Flemming Pociot Jesper Johannesen Peter Rossing Cristina Legido‐Quigley Roberto Mallone Raphaël Scharfmann Christian Boîtard Mikael Knip Timo Otonkoski Riitta Veijola Riitta Lahesmaa Matej Orešič Jorma Toppari Thomas Danne Anette G. Ziegler Peter Achenbach Teresa Rodríguez-Calvo Michele Solimena Ezio Bonifacio Stephan Speier Reinhard W. Holl Francesco Dotta Francesco Chiarelli Piero Marchetti Emanuele Bosi Stefano Cianfarani Paolo Ciampalini Carine de Beaufort Knut Dahl‐Jørgensen Torild Skrivarhaug Geir Joner Lars Krogvold Przemysława Jarosz‐Chobot Tadej Battelino Bernard Thorens Martin Gotthardt Bart O. Roep Tatjana Nikolić Arnaud Zaldumbide Åke Lernmark Marcus Lundgren Guillaume Costacalde Thorsten Strube Anke M. Schulte Almut Nitsche Mark Peakman José Luis Vela Matthias von Herrath Johnna D. Wesley Antonella Napolitano-Rosen Mélissa Thomas Nanette C. Schloot Allison B. Goldfine Frank Waldron-Lynch Jill Kompa Aruna Vedala

Type 1 diabetes is a complex heterogenous autoimmune disease without therapeutic interventions available to prevent or reverse the disease. This study aimed identify transcriptional changes associated with progression in patients recent-onset type diabetes.Whole-blood samples were collected as part of INNODIA at baseline and 12 months after diagnosis diabetes. We used linear mixed-effects modelling on RNA-seq data genes age, sex, progression. Cell-type proportions estimated from using...

10.1016/j.ebiom.2023.104625 article EN cc-by EBioMedicine 2023-05-22

Abstract Aims/hypothesis Type 1 diabetes is a chronic autoimmune disease of complex aetiology, including potential role for epigenetic regulation. Previous epigenomic studies focused mainly on clinically diagnosed individuals. The aim the study was to assess early DNA methylation changes associated with type already before diagnosis or even appearance autoantibodies. Methods Reduced representation bisulphite sequencing (RRBS) applied in purified CD4 + T cell, CD8 cell and − fractions 226...

10.1007/s00125-022-05657-x article EN cc-by Diabetologia 2022-02-10

Previous studies have revealed heterogeneity in the progression to clinical type 1 diabetes children who develop islet-specific antibodies either insulin (IAA) or glutamic acid decarboxylase (GADA) as first autoantibodies. Here, we test hypothesis that later disease different early immune responses, depending on of autoantibody appear (GADA-first IAA-first). We use mass cytometry for deep profiling peripheral blood mononuclear cell samples longitudinally collected from progressed (IAA-first,...

10.1038/s41467-024-47918-w article EN cc-by Nature Communications 2024-05-07

The transcriptional network and protein regulators that govern T helper 17 (Th17) cell differentiation have been studied extensively using advanced genomic approaches. For a better understanding of these biological processes, we moved step forward, from gene- to protein-level characterization Th17 cells. Mass spectrometry-based label-free quantitative (LFQ) proteomics analysis were made in vitro differentiated murine induced regulatory (iTreg) More than 4,000 proteins, covering almost all...

10.1371/journal.pbio.2004194 article EN cc-by PLoS Biology 2018-05-31

Abstract Clonal hematopoiesis (CH) becomes more prevalent with age and may impact the pathophysiology of inflammatory diseases by altering immune cell function. While clonal indeterminate potential (CHIP) can promote inflammation in non-malignant conditions, relationship rheumatoid arthritis (RA) has not been systematically investigated. We tested whether CHIP mutations are common RA using two population-level cohorts newly diagnosed patients. was associated FINRISK study 10 089 participants...

10.1101/2024.10.10.24315184 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-10-13

Women are more frequently affected by autoimmune disorders than men. A role for estrogen was suggested the observation that development of inflammatory bowel disease associated with oral contraceptive use. also respond to infection and vaccination higher antibody production a T helper 2 (TH2) cell–dominant immune responses, whereas men usually show TH1 cell–biased responses.

10.1530/ey.15.14.1 article EN Yearbook of pediatric endocrinology 2018-09-11
Coming Soon ...